Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
KYTX
MYGN
Add up to 3 more stocks
KYTX
Kyverna Therapeutics, Inc.
-2.72%
$6.15-0.17Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$373.79M
52W Range
$5.30 - $13.67
MYGN
Myriad Genetics, Inc.
-5.90%
$4.31-0.27Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$407.07M
52W Range
$2.74 - $8.59
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.26 | 1.34 |
| P/S Ratio | N/A | 0.50 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 68.8% |
| Operating Margin | 0.0% | -12.2% |
| Net Margin | 0.0% | -14.0% |
| ROE | -92.2% | -37.0% |
| ROA | -69.4% | -17.6% |
| ROIC | -80.7% | -19.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 9.06 | 2.21 |
| Quick Ratio | 9.06 | 1.98 |
| Debt/Equity | 0.20 | 0.69 |
| Interest Coverage | -347.29 | -6.46 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.